Chronix Teams with Hemispherx on Chronic Fatigue MDx
March 03, 2011
Chronix Teams with Hemispherx on Chronic Fatigue MDx
Chronix is developing a test based on its circulating DNA detection technology that will be tested in studies of how patients respond to Hemispherx's experimental drug Ampligen.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.